JPMorgan Chase & Co. Boosts Envista (NYSE:NVST) Price Target to $29.00

Envista (NYSE:NVSTGet Free Report) had its price target increased by investment analysts at JPMorgan Chase & Co. from $26.00 to $29.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target points to a potential upside of 18.13% from the company’s previous close.

Several other equities research analysts also recently weighed in on NVST. Barclays upped their target price on Envista from $24.00 to $34.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 11th. Leerink Partners set a $35.00 target price on Envista and gave the stock an “outperform” rating in a research report on Friday, February 6th. Piper Sandler reaffirmed a “neutral” rating and issued a $25.00 target price (up from $21.00) on shares of Envista in a research report on Friday, February 6th. Wells Fargo & Company upped their target price on Envista from $21.00 to $26.00 and gave the stock an “equal weight” rating in a research report on Friday, February 6th. Finally, William Blair raised Envista from a “hold” rating to an “outperform” rating in a research report on Friday, February 6th. Six research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $28.83.

Get Our Latest Report on Envista

Envista Trading Down 9.3%

NYSE:NVST traded down $2.52 on Thursday, hitting $24.55. 9,194,392 shares of the stock were exchanged, compared to its average volume of 2,815,126. The stock has a market cap of $4.00 billion, a PE ratio of 87.18, a PEG ratio of 1.79 and a beta of 0.92. The company has a current ratio of 2.38, a quick ratio of 2.04 and a debt-to-equity ratio of 0.47. The stock has a fifty day moving average of $26.63 and a 200-day moving average of $24.03. Envista has a fifty-two week low of $16.41 and a fifty-two week high of $30.42.

Envista (NYSE:NVSTGet Free Report) last issued its earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.05. Envista had a return on equity of 6.54% and a net margin of 1.73%.The company had revenue of $705.50 million during the quarter, compared to the consensus estimate of $680.04 million. During the same quarter in the prior year, the business earned $0.24 earnings per share. The company’s revenue was up 14.4% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, equities analysts expect that Envista will post 1.4 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, SVP Mischa Reis sold 9,675 shares of the stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total value of $290,250.00. Following the completion of the transaction, the senior vice president owned 32,382 shares of the company’s stock, valued at approximately $971,460. This represents a 23.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 0.99% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Parallel Advisors LLC boosted its holdings in Envista by 13.1% in the fourth quarter. Parallel Advisors LLC now owns 3,175 shares of the company’s stock valued at $69,000 after purchasing an additional 367 shares during the last quarter. Bank of Montreal Can boosted its holdings in Envista by 1.4% in the fourth quarter. Bank of Montreal Can now owns 26,178 shares of the company’s stock valued at $568,000 after purchasing an additional 372 shares during the last quarter. Sepio Capital LP boosted its holdings in Envista by 1.2% in the fourth quarter. Sepio Capital LP now owns 31,632 shares of the company’s stock valued at $687,000 after purchasing an additional 374 shares during the last quarter. Deutsche Bank AG raised its stake in Envista by 2.9% during the fourth quarter. Deutsche Bank AG now owns 17,412 shares of the company’s stock valued at $378,000 after buying an additional 484 shares in the last quarter. Finally, State of Michigan Retirement System raised its stake in Envista by 1.5% during the first quarter. State of Michigan Retirement System now owns 39,463 shares of the company’s stock valued at $1,001,000 after buying an additional 600 shares in the last quarter.

Key Stories Impacting Envista

Here are the key news stories impacting Envista this week:

  • Positive Sentiment: Q1 beat — Envista delivered $0.36 EPS vs. $0.31 consensus and revenue of $705.5M vs. ~$680M, with organic revenue up ~14% year-over-year, showing broad-based strength. Envista Reports First Quarter 2026 Results
  • Positive Sentiment: Analyst upgrade — Robert W. Baird raised its price target to $31 and kept an Outperform rating, signaling buy-side confidence in the company’s growth trajectory. Benzinga
  • Positive Sentiment: Street commentary highlights new growth drivers and operating leverage potential that could expand margins if revenue momentum continues. Envista: Spotlight On Q1 Outperformance And New Growth Drivers
  • Neutral Sentiment: FY‑2026 guidance set to $1.35–$1.45 EPS (midpoint ~1.40), essentially in line with consensus — helps visibility but doesn’t materially raise expectations. Envista FY2026 Guidance (Press Release/Slides)
  • Neutral Sentiment: Earnings call and transcript provide color on geographic trends, product mix, and margin drivers — useful for judging sustainability of the beat. Q1 2026 Earnings Call Transcript
  • Negative Sentiment: Profitability concerns — net margin remains low (~1.7%) and valuation is rich (high P/E), which could limit upside if margin expansion or guidance beats don’t materialize. Analysts and metric reviews flagged areas to monitor. Here’s What Key Metrics Tell Us About Envista (NVST) Q1 Earnings

About Envista

(Get Free Report)

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.

See Also

Analyst Recommendations for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.